FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:2407-2415 December 18, 2003 Number 25 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Perspective by Hahn, B. H. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Premature coronary artery disease is a major cause of illness and death in patients with systemic lupus erythematosus, but little is known about the prevalence, extent, and causes of coronary-artery atherosclerosis.

Methods We used electron-beam computed tomography to screen for the presence of coronary-artery calcification in 65 patients with systemic lupus erythematosus (mean [±SD] age, 40.3±11.6 years) and 69 control subjects (mean age, 42.7±12.6 years) with no history of coronary artery disease. When calcification was detected, the extent was measured by means of the Agatston score. The frequency of risk factors for coronary artery disease was compared in patients and controls, and the relation between the patients' clinical characteristics and the presence or absence of coronary-artery calcification was examined.

Results The two groups were similar with respect to age, race, and sex. Coronary-artery calcification was more frequent in patients with lupus (20 of 65 patients) than in control subjects (6 of 69 subjects) (P=0.002). The mean calcification score was 68.9±244.2 in the patients and 8.8±41.8 (P<0.001) in controls. Levels of total, high-density lipoprotein, and low-density lipoprotein cholesterol were not elevated in patients with lupus, but levels of triglycerides (P=0.02) and homocysteine (P<0.001) were. Among patients with lupus, measures of disease activity were similar in those with and those without coronary-artery calcification, but those with calcification were more likely to be older (P<0.001) and male (P=0.008).

Conclusions In patients with systemic lupus erythematosus, the prevalence of coronary-artery atherosclerosis is elevated and the age at onset is reduced. Early detection of atherosclerosis may provide an opportunity for therapeutic intervention.

Source Information

From the Divisions of Clinical Pharmacology (Y.A., A.O., C.M.S.), General Internal Medicine (A.K.S.), Rheumatology (E.T., N.O., C.M.S.), and Cardiovascular Medicine (S.F., M.F.L.), Vanderbilt University School of Medicine, Nashville; and the Section of Cardiology, Tulane University School of Medicine, New Orleans (P.R.).

Full Text of this Article

Related Letters:

Premature Coronary Disease in Systemic Lupus
Wurzel J., Goldman B. I., Doria A., Shoenfeld Y., Pauletto P., Violi F., Loffredo L., Ferro D., Pezzetta F., Mascitelli L., Noël B., Roman M. J., Lockshin M. D., Salmon J. E., Stein C. M., Hahn B. H.
Extract | Full Text | PDF  
N Engl J Med 2004; 350:1571-1575, Apr 8, 2004. Correspondence

This article has been cited by other articles:

• Shang, Q, Tam, L., Li, E., Yip, G., Yu, C. (2008). Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus. Lupus 17: 1096-1102 [Abstract]  
• Chan, M. Y., Andreotti, F., Becker, R. C. (2008). Hypercoagulable States in Cardiovascular Disease. Circulation 118: 2286-2297 [Full Text]  
• Grisar, J., Steiner, C. W., Bonelli, M., Karonitsch, T., Schwarzinger, I., Weigel, G., Steiner, G., Smolen, J. S. (2008). Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells. Rheumatology (Oxford) 47: 1476-1483 [Abstract] [Full Text]  
• Sabio, J., Zamora-Pasadas, M, Jimenez-Jaimez, J, Albadalejo, F, Vargas-Hitos, J, Rodriguez del Aguila, M., Hidalgo-Tenorio, C, Gonzalez-Gay, M., Alonso, J. (2008). Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Lupus 17: 849-859 [Abstract]  
• Mandelbrot, D. A., Santos, P. W., Burt, R. K., Oyama, Y., Block, G. A., Ahya, S. N., Rosa, R. M., Traynor, A. E. (2008). Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation. Nephrol Dial Transplant 23: 2679-2684 [Abstract] [Full Text]  
• Roldan, C. A (2008). Valvular and coronary heart disease in systemic inflammatory diseases. Heart 94: 1089-1101 [Full Text]  
• Mathieu, S., Joly, H., Baron, G., Tournadre, A., Dubost, J.-J., Ristori, J.-M., Lusson, J.-R., Soubrier, M. (2008). Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology (Oxford) 47: 1203-1207 [Abstract] [Full Text]  
• Wright, S A, O'Prey, F M, McHenry, M T, Leahey, W J, Devine, A B, Duffy, E M, Johnston, D G, Finch, M B, Bell, A L, McVeigh, G E (2008). A randomised interventional trial of {omega}-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis 67: 841-848 [Abstract] [Full Text]  
• Frostegard, J (2008). Systemic lupus erythematosus and cardiovascular disease. Lupus 17: 364-367 [Abstract]  
• Shoenfeld, Y., Meroni, P. L., Cervera, R. (2008). Antiphospholipid syndrome dilemmas still to be solved: 2008 status. Ann Rheum Dis 67: 438-442 [Full Text]  
• Lee, S-S., Singh, S., Magder, L., Petri, M. (2008). Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus. Lupus 17: 114-123 [Abstract]  
• Bertsias, G, Ioannidis, J P A, Boletis, J, Bombardieri, S, Cervera, R, Dostal, C, Font, J, Gilboe, I M, Houssiau, F, Huizinga, T, Isenberg, D, Kallenberg, C G M, Khamashta, M, Piette, J C, Schneider, M, Smolen, J, Sturfelt, G, Tincani, A, van Vollenhoven, R, Gordon, C, Boumpas, D T (2008). EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67: 195-205 [Abstract] [Full Text]  
• Avalos, I., Chung, C. P., Oeser, A., Milne, G. L., Borntrager, H., Morrow, J. D., Raggi, P., Solus, J., Stein, C. M. (2007). Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus. Lupus 16: 981-986 [Abstract]  
• Roman, M. J., Salmon, J. E. (2007). Cardiovascular Manifestations of Rheumatologic Diseases. Circulation 116: 2346-2355 [Full Text]  
• Lazzerini, P.E., Capecchi, P.L., Selvi, E., Lorenzini, S., Bisogno, S., Galeazzi, M., Laghi Pasini, F. (2007). Hyperhomocysteinemia: a cardiovascular risk factor in autoimmune diseases?. Lupus 16: 852-862 [Abstract]  
• Martinez-Berriotxoa, A., Ruiz-Irastorza, G., Egurbide, M.-V., Garmendia, M., Gabriel Erdozain, J., Villar, I., Aguirre, C. (2007). Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Lupus 16: 810-816 [Abstract]  
• Knockaert, D. C. (2007). Cardiac involvement in systemic inflammatory diseases. Eur Heart J 28: 1797-1804 [Abstract] [Full Text]  
• O'Neill, S. G, Isenberg, D. A, Rahman, A. (2007). Could antibodies to C-reactive protein link inflammation and cardiovascular disease in patients with systemic lupus erythematosus?. Ann Rheum Dis 66: 989-991 [Full Text]  
• Gautier, E. L., Huby, T., Ouzilleau, B., Doucet, C., Saint-Charles, F., Gremy, G., Chapman, M. J., Lesnik, P. (2007). Enhanced Immune System Activation and Arterial Inflammation Accelerates Atherosclerosis in Lupus-Prone Mice. Arterioscler. Thromb. Vasc. Bio. 27: 1625-1631 [Abstract] [Full Text]  
• Edwards, N. C., Ferro, C. J., Townend, J. N., Steeds, R. P. (2007). Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance. Rheumatology (Oxford) 46: 1208-1209 [Full Text]  
• Ahmad, Y., Shelmerdine, J., Bodill, H., Lunt, M., Pattrick, M. G., Teh, L. S., Bernstein, R. M., Walker, M. G., Bruce, I. N. (2007). Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. Rheumatology (Oxford) 46: 983-988 [Abstract] [Full Text]  
• Chaiamnuay, S., Bertoli, A. M, Roseman, J. M, McGwin, G., Apte, M., Duran, S., Vila, L. M, Reveille, J. D, Alarcon, G. S (2007). African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV). Ann Rheum Dis 66: 618-622 [Abstract] [Full Text]  
• Ait-Oufella, H., Kinugawa, K., Zoll, J., Simon, T., Boddaert, J., Heeneman, S., Blanc-Brude, O., Barateau, V., Potteaux, S., Merval, R., Esposito, B., Teissier, E., Daemen, M. J., Leseche, G., Boulanger, C., Tedgui, A., Mallat, Z. (2007). Lactadherin Deficiency Leads to Apoptotic Cell Accumulation and Accelerated Atherosclerosis in Mice. Circulation 115: 2168-2177 [Abstract] [Full Text]  
• Korkmaz, C., Cansu, D.U., Kasifoglu, T. (2007). Myocardial infarction in young patients (<=35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature. Lupus 16: 289-297 [Abstract]  
• von Lukowicz, T., Silacci, M., Wyss, M. T., Trachsel, E., Lohmann, C., Buck, A., Luscher, T. F., Neri, D., Matter, C. M. (2007). Human Antibody Against C Domain of Tenascin-C Visualizes Murine Atherosclerotic Plaques Ex Vivo. JNM 48: 582-587 [Abstract] [Full Text]  
• Feng, X., Li, H., Rumbin, A. A., Wang, X., La Cava, A., Brechtelsbauer, K., Castellani, L. W., Witztum, J. L., Lusis, A. J., Tsao, B. P. (2007). ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. J. Lipid Res. 48: 794-805 [Abstract] [Full Text]  
• Avalos, I, Chung, C P, Oeser, A, Milne, G L, Morrow, J D, Gebretsadik, T, Shintani, A, Yu, C, Stein, C M (2007). Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus 16: 195-200 [Abstract]  
• Chung, C. P, Avalos, I., Oeser, A., Gebretsadik, T., Shintani, A., Raggi, P., Michael Stein, C (2007). High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 66: 208-214 [Abstract] [Full Text]  
• Kavey, R.-E. W., Allada, V., Daniels, S. R., Hayman, L. L., McCrindle, B. W., Newburger, J. W., Parekh, R. S., Steinberger, J. (2006). Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 114: 2710-2738 [Abstract] [Full Text]  
• La Rosa, J C (2006). Atherosclerotic vascular disease in systemic lupus erythematosus and related disorders. Lupus 15: 35-38 [Abstract]  
• Sinclair, A, Baildon, R (2006). Mycophenolate mofetil: an overview. Lupus 15: 70-77  
• Yang, M.-L., Doyle, H. A., Gee, R. J., Lowenson, J. D., Clarke, S., Lawson, B. R., Aswad, D. W., Mamula, M. J. (2006). Intracellular Protein Modification Associated with Altered T Cell Functions in Autoimmunity. J. Immunol. 177: 4541-4549 [Abstract] [Full Text]  
• Chung, C P, Oeser, A, Avalos, I, Raggi, P, Stein, C M (2006). Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus. Lupus 15: 562-569 [Abstract]  
• Ruiz-Irastorza, G, Egurbide, M-V, Pijoan, J-I, Garmendia, M, Villar, I, Martinez-Berriotxoa, A, Erdozain, J-G, Aguirre, C (2006). Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 15: 577-583 [Abstract]  
• Bagi, Z, Hamar, P, Kardos, M, Koller, A (2006). Lack of flow mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice. Lupus 15: 326-334 [Abstract]  
• Stanic, A. K., Stein, C. M., Morgan, A. C., Fazio, S., Linton, M. F., Wakeland, E. K., Olsen, N. J., Major, A. S. (2006). Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 103: 7018-7023 [Abstract] [Full Text]  
• D'Cruz, D. P (2006). Systemic lupus erythematosus.. BMJ 332: 890-894 [Full Text]  
• Mannino, D. M., Watt, G., Hole, D., Gillis, C., Hart, C., McConnachie, A., Davey Smith, G., Upton, M., Hawthorne, V., Sin, D. D., Man, S. F. P., Van Eeden, S., Mapel, D. W., Vestbo, J. (2006). The natural history of chronic obstructive pulmonary disease.. Eur Respir J 27: 627-643 [Full Text]  
• Shaw, L. J., Bairey Merz, C. N., Pepine, C. J., Reis, S. E., Bittner, V., Kelsey, S. F., Olson, M., Johnson, B. D., Mankad, S., Sharaf, B. L., Rogers, W. J., Wessel, T. R., Arant, C. B., Pohost, G. M., Lerman, A., Quyyumi, A. A., Sopko, G., for the WISE Investigators, (2006). Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies. J Am Coll Cardiol 47: S4-S20 [Abstract] [Full Text]  
• Garcia, M A, Marcos, J C, Marcos, A I, Pons-Estel, B A, Wojdyla, D, Arturi, A, Babini, J C, Catoggio, L J, Alarcon-Segovia, D (2005). Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus 14: 938-946 [Abstract]  
• Lin, C.-H., Lee, M.-L., Hsu, R.-B. (2005). Cardiac surgery in patients with systemic lupus erythematosus. ICVTS 4: 618-621 [Abstract] [Full Text]  
• Hall, F. C., Dalbeth, N. (2005). Disease modification and cardiovascular risk reduction: two sides of the same coin?. Rheumatology (Oxford) 44: 1473-1482 [Abstract] [Full Text]  
• Bruce, I. N. (2005). 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford) 44: 1492-1502 [Abstract] [Full Text]  
• Mineo, C., Gormley, A. K., Yuhanna, I. S., Osborne-Lawrence, S., Gibson, L. L., Hahner, L., Shohet, R. V., Black, S., Salmon, J. E., Samols, D., Karp, D. R., Thomas, G. D., Shaul, P. W. (2005). Fc{gamma}RIIB Mediates C-Reactive Protein Inhibition of Endothelial NO Synthase. Circ. Res. 97: 1124-1131 [Abstract] [Full Text]  
• Cardoso, C R., Sales, M A., Papi, J A., Salles, G F (2005). QT-interval parameters are increased in systemic lupus erythematosus patients. Lupus 14: 846-852 [Abstract]  
• Feinbloom, D., Bauer, K. A. (2005). Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events. Arterioscler. Thromb. Vasc. Bio. 25: 2043-2053 [Abstract] [Full Text]  
• Pinn, V. W. (2005). Research on Women's Health: Progress and Opportunities. JAMA 294: 1407-1410 [Full Text]  
• Frostegard, J. (2005). Atherosclerosis in Patients With Autoimmune Disorders. Arterioscler. Thromb. Vasc. Bio. 25: 1776-1785 [Abstract] [Full Text]  
• Calvo-Alen, J., Alarcon, G. S., Campbell, R. Jr, Fernandez, M., Reveille, J. D., Cooper, G. S. (2005). Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology (Oxford) 44: 1186-1189 [Abstract] [Full Text]  
• Barnes, E V, Narain, S, Naranjo, A, Shuster, J, Segal, M S, Sobel, E S, Armstrong, A E, Santiago, B E, Reeves, W H, Richards, H B (2005). High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus 14: 576-582 [Abstract]  
• Binstadt, B. A., Levine, J. C., Nigrovic, P. A., Gauvreau, K., Dedeoglu, F., Fuhlbrigge, R. C., Weindling, S. N., Newburger, J. W., Sundel, R. P. (2005). Coronary Artery Dilation Among Patients Presenting With Systemic-Onset Juvenile Idiopathic Arthritis. Pediatrics 116: e89-e93 [Abstract] [Full Text]  
• Buyon, J. P., Petri, M. A., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Merrill, J. T., Sammaritano, L., Lockshin, M., Alarcon, G. S., Manzi, S., Belmont, H. M., Askanase, A. D., Sigler, L., Dooley, M. A., Von Feldt, J., McCune, W. J., Friedman, A., Wachs, J., Cronin, M., Hearth-Holmes, M., Tan, M., Licciardi, F. (2005). The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial. ANN INTERN MED 142: 953-962 [Abstract] [Full Text]  
• Birdas, T. J., Landis, J. T., Haybron, D., Evers, D., Papasavas, P. K., Caushaj, P. F. (2005). Outcomes of Coronary Artery Bypass Grafting in Patients With Connective Tissue Diseases. Ann. Thorac. Surg. 79: 1610-1614 [Abstract] [Full Text]  
• Andreotti, F., Becker, R. C. (2005). Atherothrombotic Disorders: New Insights From Hematology. Circulation 111: 1855-1863 [Full Text]  
• Jadoul, M (2005). Optimal care of lupus nephritis patients. Lupus 14: 72-76 [Abstract]  
• Cederholm, A., Svenungsson, E., Jensen-Urstad, K., Trollmo, C., Ulfgren, A.-K., Swedenborg, J., Fei, G.-Z., Frostegard, J. (2005). Decreased Binding of Annexin V to Endothelial Cells: A Potential Mechanism in Atherothrombosis of Patients With Systemic Lupus Erythematosus. Arterioscler. Thromb. Vasc. Bio. 25: 198-203 [Abstract] [Full Text]  
• Marasini, B, De Monti, M, Ghilardi, G (2005). Risk factors for accelerated atherosclerosis in patients with systemic lupus erythematosus. Ann Rheum Dis 64: 163-164 [Full Text]  
• Hellmann, D. B. (2004). Update in Rheumatology. ANN INTERN MED 141: 801-804 [Full Text]  
• Seyahi, E., Memisoglu, E., Hamuryudan, V., Tepe, S., Aker, U. T., Balci, H., Ongen, Z., Yurdakul, S., Yazici, H. (2004). Coronary atherosclerosis in Behcet's syndrome: a pilot study using electron-beam computed tomography. Rheumatology (Oxford) 43: 1448-1450 [Full Text]  
• Sabio, J. M., Jimenez-Alonso, J., Tanvetyanon, T., Jacobsen, S., Garred, P. (2004). Arterial Thrombosis in Systemic Lupus Erythematosus. NEJM 351: 1910-1911 [Full Text]  
• Houssiau, F. A. (2004). Management of Lupus Nephritis: An Update. J. Am. Soc. Nephrol. 15: 2694-2704 [Full Text]  
• Bruce, I. N (2004). Coronary heart disease (CHD) in lupus: round up the usual suspects?. Lupus 13: 557-560  
• Gorman, C., Isenberg, D. (2004). Atherosclerosis and lupus. Rheumatology (Oxford) 43: 943-945 [Full Text]  
• Ohlenschlaeger, T., Garred, P., Madsen, H. O., Jacobsen, S. (2004). Mannose-Binding Lectin Variant Alleles and the Risk of Arterial Thrombosis in Systemic Lupus Erythematosus. NEJM 351: 260-267 [Abstract] [Full Text]  
• Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., Grunfeld, C. (2004). Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196 [Abstract] [Full Text]  
• Wurzel, J., Goldman, B. I., Doria, A., Shoenfeld, Y., Pauletto, P., Violi, F., Loffredo, L., Ferro, D., Pezzetta, F., Mascitelli, L., Noel, B., Roman, M. J., Lockshin, M. D., Salmon, J. E., Stein, C. M., Hahn, B. H. (2004). Premature Coronary Disease in Systemic Lupus. NEJM 350: 1571-1575 [Full Text]  
• (2004). Lupus: Atherosclerosis Risk Factor. Journal Watch Cardiology 2004: 1-1 [Full Text]  
• Malik, I. (2004). JournalScan. Heart 90: 353-354 [Full Text]  
• Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., Salmon, J. E. (2003). Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus. NEJM 349: 2399-2406 [Abstract] [Full Text]